Association between Posttreatment Serum Platelet-to-Lymphocyte Ratio and Distant Metastases in Patients with Hepatocellular Carcinoma Receiving Curative Radiation Therapy.
Dong Soo LeeChang Wook KimHee Yeon KimYoung-Mi KuYoo Dong WonSu-Lim LeeDer Sheng SunPublished in: Cancers (2023)
Posttreatment serum PLR might be helpfully used as a predictive biomarker of DM in unresectable HCC patients undergoing RT. Future research is necessary to confirm our findings.